Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection Vs. Endoscopic Submucosal Dissection

Colorectal cancer is one of the leading causes of cancer-related mortality worldwide. Early-stage non-polypoid neoplastic lesions, particularly Laterally Spreading Tumors - Granular Type (LST-G) larger than 20mm, require effective endoscopic removal to prevent malignant progression. The two primary techniques for resecting these lesions are Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). EMR is a widely used, minimally invasive technique that involves resecting the lesion with a diathermic snare after submucosal injection. While effective and safe, EMR often nec

Trial Details

NCT ID
NCT06815406
Phase
NA
Sponsor
Azienda USL Reggio Emilia - IRCCS
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Endoscopic Mucosal Resection (EMR)
  • Endoscopic Submucosal Dissection (ESD)
Locations (sample)
  • Bologna, Italy|44.49381,11.33875
  • Genova, Italy|45.21604,11.87211
  • Milan, Italy|42.78235,12.59836
  • Modena, Italy|44.64783,10.92539
  • Reggio Emilia, Italy|44.69825,10.63125

Key Eligibility Criteria

  • Age ≥ 18 years.
  • Diagnosis of Laterally Spreading Tumor - Granular Type (LST-G) ≥ 20 mm in the colon or rectum with an indication for endoscopic resection.
  • Life expectancy \> 10 years.
  • Ability to understand and sign the informed consent form, demonstrating comprehension of the study and willingness to participate.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →